Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProteinSimple was a US-based biotechnology company specializing in the development of proprietary automated systems and consumables for protein analysis. Its innovative platforms such as Simple Western™, Maurice™, and Ella™ transformed traditional western blotting, capillary electrophoresis immunoassays, and ELISA workflows by automating processes that were previously labor-intensive. In August 2014, ProteinSimple was acquired by Bio-Techne Corporation for $300 million USD. Since then it has operated as a brand/division within Bio-Techne’s extensive life science reagents/instrumentation business serving academic researchers as well as biopharma R&D globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProteinSimple.